Atopic Dermatitis Pipeline Review and Therapeutics, H1 2015

Press Release   •   Aug 06, 2015 04:16 EDT

Atopic dermatitis is a disease in child below 1 year and causes itchy skin, It is the common disease in child below 1 year and are been identified by different names. This report provides comprehensive information on the therapeutic development for Atopic Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Inquire more about this report at . (This is a premium report price at US$2000 for a single user PDF license)

It also reviews key players involved in the therapeutic development for Atopic Dermatitis and special features on late-stage and discontinued projects.

The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Complete Report is available at .

Scope of the Report:

  • The report provides a snapshot of the global therapeutic landscape of Atopic Dermatitis
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Atopic Dermatitis and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Atopic Dermatitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects

Inquire for discount of this report at . (This is a premium report price at US$2000 for a single user PDF license)

Reasons to buy:

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Atopic Dermatitis
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Atopic Dermatitis pipeline depth and focus of Indication therapeutics

Table of Contents:

Table of Contents 2
List of Tables 6
List of Figures 10
Introduction 11
Global Markets Direct Report Coverage 11
Atopic Dermatitis Overview 12
Therapeutics Development 13
Pipeline Products for Atopic Dermatitis - Overview 13
Pipeline Products for Atopic Dermatitis - Comparative Analysis 14
Atopic Dermatitis - Therapeutics under Development by Companies 15
Atopic Dermatitis - Therapeutics under Investigation by Universities/Institutes 22
Atopic Dermatitis - Pipeline Products Glance 23

More reports on Dermatology therapeutics are available at .